Ukrain

Title Average Ratingsort ascending
Why is not Ukrain approved yet in Austria/EU? 98.57%
Ukrain (NSC-631570) in the treatment of pancreas cancer. 95.00%
Effect of Ukrain on the growth and metastasizing of Lewis carcinoma in C57BL/6 mice 90.00%
Clinical Investigations on Ukrain 90.00%
Pre-Clinical Investigations on Ukrain 90.00%
Retrospective study of Ukrain treatment in 203 patients with advanced-stage tumors 90.00%
WHO’S AFRAID OF A CURE FOR CANCER? - The struggle for an alternative cancer drug 90.00%
Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis. 90.00%
Chemical analyses of Ukrain, a semi-synthetic Chelidonium majus alkaloid derivative, fail to confirm its trimeric structure 90.00%
71 year old woman, Pancraetic cancer with liver and lung metastasis. 90.00%
In-vitro toxicity of Ukrain against human Ewing tumor cell lines. 90.00%
Debate in Lancet about setting up a phase II trial on Ukrain in England 90.00%
Ukrain - a new cancer cure? A systematic review of randomised clinical trials. 90.00%
NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial 85.00%
Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway. 80.00%
Ukrain, an alkaloid thiophosphoric acid derivative of Chelidonium majus L. protects human fibroblasts but not human tumour ce 80.00%
Ukrain Debate 1: What is the active Substance of Ukrain? 80.00%
Interaction between Ukrain and Naltrexone in the writhing syndrome test in mice 80.00%
The influence of glucose, succinate, pH of the medium and higher temperature on the cytotoxic activity of the preparation Ukrain 80.00%
Comparison of chemotherapy and X-ray therapy with Ukrain monotherapy for colorectal cancer 80.00%
National Cancer Institute, National Institute of Health: Developmental Therapeutics Program. NSC 631570: results of the Human Ce 80.00%
The dynamics of concentration of the main fluorescent component of Ukrain in the tissues and blood plasma of rats with W-256 ... 80.00%
Comparative evaluation of the complex treatment of rectal cancer patients (chemotherapy and X-ray therapy, Ukrain monotherapy) 80.00%
Ukrain therapy of recurrent breast cancer with lung metastases (case report) 80.00%
Clinical studies of Ukrain in terminal cancer patients (phase II) 80.00%
Effect of Ukrain on matrix metalloproteinase-2 and Secreted Protein Acidic and Rich in Cysteine (SPARC) expression in human.... 80.00%
Inhibition of liver mitochondrial monoamine oxidase activity by alkaloids isolated from Chelidonium and Macleaya and by their de 80.00%
The antimitotic effects of Ukrain, a Chelidonium majus alkaloid derivative, are reversible in vitro. 80.00%
Potential therapeutic efficacy of Ukrain (NSC 631570) in AIDS patients with Kaposi's sarcoma 80.00%
Ukrain monotherapy in malignant melanoma (case report) 80.00%
Ukrain acts by inhibition of tubulin polymerization in normal and malignant cell lines. 80.00%
Induced G2/M arrest and apoptosis in human epidermoid carcinoma cell lines by semisynthetic drug Ukrain 80.00%
Effect of some isoquinoline alkaloids on enzymatic activity of acetylcholinesterase and monoamine oxidase 80.00%
Induction of apoptosis in cultured Chinese hamster ovary cells by Ukrain and its synergistic action with etoposide. 80.00%
Antinociceptive effect of ten day administration of Ukrain in mice and interaction of the treatment with morphine 80.00%
Ukrain: Debated Subjects 80.00%
A comparative evaluation of the influence of the complex drug Ukrain and its components on the effects of radiation 80.00%
The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine and NSC-631570 in advanced pancreatic cancer. 75.00%
NF-kappaB does not influence the induction of apoptosis by Ukrain. 70.00%
Ukrain treatment in a patient with breast carcinoma 70.00%
The effects of chelidonine on tubulin polymerisation, cell cycle progression and selected signal transmission pathways 70.00%
Selective inhibition of in vitro cell growth by the anti-tumour drug Ukrain 70.00%
Efficacy of ukrain in the treatment of pancreatic cancer. 70.00%
Ukrain treatment in carcinoma of the oesophagus (case report) 70.00%
Preliminary results of individual therapy of chronic hepatitis C by Ukrain and interferon-alpha. 70.00%
Animal studies on Ukrain 65.00%
Comparative evaluation of the efficiency of various Ukrain doses in the combined treatment of breast cancer. 65.00%
Evaluation of Ukrain as an immunostimulant in patients with various carcinomas. 63.33%
Chelidonium majus L. (Ukrain) in the treatment of cancer patients. 63.33%
Ukrain 62.22%
Combined therapy with Ukrain and chemotherapy in ovarian cancer (case report) 60.00%
Does the Ukrain preparation protect mice against lethal doses of bacteria? 60.00%
The effects of thiophosphoric acid (Ukrain) on cervical cancer, stage IB bulky 60.00%
Ukrain treatment in carcinoma of the cervix (case report) 60.00%
Theoretical grounds and experimental confirmation of the antiviral effect of the 60.00%
Cysteine proteinases and their inhibitors in the development of mouse HA-1 hepatoma and antineoplastic therapy 60.00%
Ukrain therapy of stage T1N0M0 bladder cancer patients 60.00%
Biophysiological effects of Ukrain therapy in a patient with breast cancer (case report) 60.00%
Clinical studies of Ukrain in healthy volunteers (phase 1). 60.00%
Radiomodification effects of Ukrain, a cytostatic and immunomodulating drug, on intracellular glucocorticoid reception during sh 60.00%
Fibronectin and laminin increase resistance to ionizing radiation and the cytotoxic drug Ukrain in human tumour and normal cells 60.00%
Ukrain both as an anti cancer and immunoregulatory agent 60.00%
Preliminary studies on the effect of Ukrain on the immunological response in patients with malignant tumours. 60.00%
Bcl-2 overexpression protects human keratinocyte cells from Ukrain-induced apoptosis but not from G2/M arrest. 60.00%
The influence of the novel drug Ukrain on hemo- and immunopoiesis at the time of its maximum radioprotective effect 60.00%
New biochemical mechanisms of the anticancer effect of Ukrain in the treatment of cancer of the urinary bladder 60.00%
Lymphocyte subsets in patients with lung cancer treated with thiophosphoric acid 55.00%
Ukrain treatment in a patient with metastatic renal cell carcinoma extending to the vena cava inferior. 50.00%
Results of Ukrain monotherapy of prostate cancer 50.00%
Effect of alkaloid sanguinarine and a pharmaceutical preparation ukrain on modulation of vesicular membrane fusion and actin.... 50.00%
Ukrain (NSC-631570) influences on bone status: a review. 50.00%
A method for determination of Ukrain in blood plasma for monitoring and pharmacokinetic study 50.00%
Some pharmacological properties of prolonged administration of Ukrain in rodents 50.00%
Ukrain modulates glial fibrillary acidic protein, but not connexin 43 expression, and induces apoptosis in human cultured gliobl 50.00%
Influence of Ukrain on the nuclear thyroid hormone receptors after short-term gamma-irradiation. 50.00%
Six-week treatment with Ukrain in rabbits. Part I: Morphological parameters 50.00%
Ukrain with chemotherapy in malignant melanoma (case report) 50.00%
Comparative evaluation of blood plasma and tumor tissue amino acid pool in radiation or neoadjuvant preoperative therapies.... 50.00%
A study of the influence of a novel drug Ukrain on in vivo effects of low-dose ionizing radiation 50.00%
Morphometric and kinetic analysis of the growth of experimental sarcoma-45 in the presence of Ukrain 50.00%
Ukrain in the treatment of urethral recurrent carcinoma (case report) 50.00%
Biological activity of some thiophosphamide derivatives of alkaloids with respect to influenza virus 50.00%
Modification of antinociceptive action of morphine by Ukrain in rodents 50.00%
Comparative in vitro study of the effects of the new antitumor drug Ukrain and several cytostatic agents on the thiol groups in 50.00%
Ukrain treatment in a patient with non-seminomatous germ-cell tumour of testis (case report) 50.00%
Enhancement of macrophage tumouricidal activity by the alkaloid derivative 40.00%
Ukrain: acute toxicity after intravenous, intramuscular and oral administration in rats 40.00%
Ukrain therapy in a frontal anaplastic grade III astrocytoma (case report) 40.00%
Ukrain treatment of a patient with retroperitoneal synovial sarcoma. 35.00%
Effect of Ukrain on the efficacy of anti-epileptic drugs against maximal electroshock-induced seizures in mice. 30.00%
Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice. 30.00%
The influence of Ukrain on the growth of HA-1 tumor in mice: the role of cysteine proteinases as markers of tumor malignancy 30.00%
The immunomodulating preparation Ukrain does not induce anaphylactic sensitization in mice and guinea pigs 20.00%
Ukrain therapy of a recurrent astrocytoma of the optic nerve (case report) 20.00%
Six-week treatment with Ukrain in rabbits. Part II: Serum levels of gonadal hormones 20.00%
Clinical aspects of cancer treatment and new biochemical mechanisms of the drug Ukrain. 20.00%
Evaluation of mutagenic, genotoxic and transforming properties of Ukrain
Effect of Ukrain on human liver alcohol dehydrogenase activity in vitro.
Induced apoptosis in human prostate cancer cell line LNCaP by Ukrain.
Preliminary pharmacokinetic studies of Ukrain in rats

Pages